Tapewire

Nasdaq · USD

ORMP

ORAMED PHARMACEUTICALS INC.

Export transactions ↓
Tapewire entity
6311
SEC CIK
0001176309
Parsed reports
201

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202602
Aug 202600
Sep 202600
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 31, 2021 Filed Dec 7, 2021 21:30 UTC Amendment
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 100,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-063944 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 838,209

F1 · price: Restricted Stock Units ("RSUs") granted in February 2021 and vested upon achievement of certain vesting conditions. The RSUs convert into Issuer's common stock on a one-for-one basis.

F2 · balance_after: This amendment is being filed to correct an administrative error in Form 4 filed by Mr. Kidron, which reported that 748,573 shares of common stock are beneficially owned by him following the reported transaction. Mr. Kidron beneficially owned 838,209 shares of common stock following the reported transaction.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Exercise / conversionStock Option (right to buy) · Derivative 56,773 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · derivative · entry 12

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 56,773 shares

Expires 2027-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options vested as follows: 15,591 vested on December 31, 2017, 2018 and 2019 and additional 10,000 vested on December 31, 2020.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $4.17 $0.00
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · derivative · entry 11

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2029-09-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Exercise / conversionStock Option (right to buy) · Derivative 6,666 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · derivative · entry 10

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,666 shares

Expires 2030-01-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Exercise / conversionStock Option (right to buy) · Derivative 5,697 $0.00 Strike: $6.23 $0.00
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · derivative · entry 9

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,697 shares

Expires 2027-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Tax withholdingCommon Stock 20,916 $21.09 $441,118.44
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · nonDerivative · entry 8

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,104

F4 · shares: Represents a cashless exercise of outstanding stock options to purchase 56,773 shares of common stock. The reporting person received 35,857 shares of common stock and surrendered 20,916 shares of common stock underlying the stock option in payment of the exercise price.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Exercise / conversionCommon Stock 56,773 $7.77 $441,126.21
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · nonDerivative · entry 7

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,020

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Tax withholdingCommon Stock 1,977 $21.09 $41,694.93
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · nonDerivative · entry 6

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,247

F3 · shares: Represents a cashless exercise of outstanding stock options to purchase 10,000 shares of common stock. The reporting person received 8,023 shares of common stock and surrendered 1,977 shares of common stock underlying the stock option in payment of the exercise price.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Exercise / conversionCommon Stock 10,000 $4.17 $41,700.00
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · nonDerivative · entry 5

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,224

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Tax withholdingCommon Stock 1,517 $21.09 $31,993.53
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · nonDerivative · entry 4

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,224

F2 · shares: Represents a cashless exercise of outstanding stock options to purchase 6,666 shares of common stock. The reporting person received 5,149 shares of common stock and surrendered 1,517 shares of common stock underlying the stock option in payment of the exercise price.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Exercise / conversionCommon Stock 6,666 $4.80 $31,996.80
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · nonDerivative · entry 3

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Tax withholdingCommon Stock 1,683 $21.09 $35,494.47
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · nonDerivative · entry 2

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,075

F1 · shares: Represents a cashless exercise of outstanding stock options to purchase 5,697 shares of common stock. The reporting person received 4,014 shares of common stock and surrendered 1,683 shares of common stock underlying the stock option in payment of the exercise price.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
RAKIN KEVINDirector
Exercise / conversionCommon Stock 5,697 $6.23 $35,492.31
Disclosure

SEC source: 0001213900-21-041712 · ownership.xml · nonDerivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,758

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:15 UTC
KIDRON NADAVDirector · President and CEO · 10% owner
SaleCommon Stock 220,000 $20.11 $4,423,144.00
Disclosure

SEC source: 0001213900-21-041711 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 648,573

F1 · date: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 18, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $21.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.

Read SEC document
August 09, 2021 Filed Dec 7, 2021 21:30 UTC Amendment
KIDRON NADAVDirector · President and CEO · 10% owner
SaleCommon Stock 220,000 $20.11 $4,423,144.00
Disclosure

SEC source: 0001213900-21-063945 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 738,209

F1 · date: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 18, 2021.

F2 · price: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 18, 2021.

F3 · balance_after: This amendment is being filed to correct an administrative error in Form 4 filed by Mr. Kidron, which reported that 648,573 shares of common stock are beneficially owned by him following the reported transaction. Mr. Kidron beneficially owned 738,209 shares of common stock following the reported transaction.

Read SEC document
August 04, 2021 Filed Aug 6, 2021 20:01 UTC
Rabinowitz MichaelChief Commercial Officer
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $15.10 $0.00
Disclosure

SEC source: 0001213900-21-040761 · ownership.xml · derivative · entry 2

Rabinowitz Michael · CIK 0001767090 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2031-08-04

F3 · derivative.exercise_date: The Stock Options will vest in five installments as follows: 12,500 shall vest on December 31, 2021, 25,000 shall vest on each of December 31, 2022, December 31, 2023 and December 31, 2024, and 12,500 shall vest on August 4, 2025.

Read SEC document
August 04, 2021 Filed Aug 6, 2021 20:01 UTC
Rabinowitz MichaelChief Commercial Officer
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-040761 · ownership.xml · nonDerivative · entry 1

Rabinowitz Michael · CIK 0001767090 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

F1 · security: Represents common stock underlying Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · date: The RSUs will vest as follows: 33,333 shall vest if the closing price per share of the Issuer's common stock will be $15 for at least 20 days, 33,333 shall vest if the closing price per share of the Issuer's common stock will be $25 for at least 20 days, and 33,334 shall vest if the Issuer consummates an arm's length licensing or other strategic transaction, that includes its phase 3 oral insulin product, for no less than $50,000,000 in upfront cash (including proceeds from any upfront stock equity purchase).

Read SEC document
July 04, 2021 Filed Oct 15, 2021 21:15 UTC GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-053085 · ownership.xml · nonDerivative · entry 2

Friedman Aviad · CIK 0001683729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These shares of common stock were transferred, for no consideration, to a trust with an independent trustee.

Read SEC document
July 04, 2021 Filed Oct 15, 2021 21:15 UTC GiftCommon Stock 12,191 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-053085 · ownership.xml · nonDerivative · entry 1

Friedman Aviad · CIK 0001683729 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By wholly-owned corporation

Disclosed balance after: 0

F1 · kind: These shares of common stock were transferred, for no consideration, to a trust with an independent trustee.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:12 UTC
Sank LeonardDirector
OtherCommon Stock 78,125 $3.68 $287,500.00
Disclosure

SEC source: 0001213900-21-012894 · ownership.xml · nonDerivative · entry 2

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Via trust

Disclosed balance after: 0

F1 · kind: The reported securities were transferred to the Ledo Investment Holdings Limited trust (the "Trust"), which is administered by an independent trustee for the benefit of the reporting person and his immediate family members. The reporting person disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein.

F1 · ownership.nature: The reported securities were transferred to the Ledo Investment Holdings Limited trust (the "Trust"), which is administered by an independent trustee for the benefit of the reporting person and his immediate family members. The reporting person disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:12 UTC
Sank LeonardDirector
OtherCommon Stock 375,000 $3.68 $1,380,000.00
Disclosure

SEC source: 0001213900-21-012894 · ownership.xml · nonDerivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Via trust

Disclosed balance after: 0

F1 · kind: The reported securities were transferred to the Ledo Investment Holdings Limited trust (the "Trust"), which is administered by an independent trustee for the benefit of the reporting person and his immediate family members. The reporting person disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein.

F2 · shares: Due to an administrative rounding error following the Issuer's 1-to-12 reverse stock split, which occurred on January 10, 2013, the Form 4 filed for the reporting person on February 11, 2013 inadvertently understated the amount of shares beneficially owned by the reporting person following the transaction by 1 share, which error has been corrected on this Form 4.

F1 · ownership.nature: The reported securities were transferred to the Ledo Investment Holdings Limited trust (the "Trust"), which is administered by an independent trustee for the benefit of the reporting person and his immediate family members. The reporting person disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein.

Read SEC document
February 17, 2021 Filed Feb 17, 2021 21:21 UTC
RAKIN KEVINDirector
GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $11.33 $0.00
Disclosure

SEC source: 0001213900-21-010094 · ownership.xml · derivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2031-02-17

F1 · kind: The Stock Option will vest in 4 equal installments as follows: 3,750 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

F1 · derivative.exercise_date: The Stock Option will vest in 4 equal installments as follows: 3,750 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

Read SEC document
February 03, 2021 Filed Feb 8, 2021 22:30 UTC
KIDRON NADAVDirector · President and CEO · 10% owner
GrantStock Option (right to buy) · Derivative 150,000 $0.00 Strike: $10.40 $0.00
Disclosure

SEC source: 0001213900-21-007499 · ownership.xml · derivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2031-02-03

F1 · kind: The Stock Option will vest in 4 equal installments as follows: 37,500 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

F1 · derivative.exercise_date: The Stock Option will vest in 4 equal installments as follows: 37,500 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

Read SEC document
February 03, 2021 Filed Feb 8, 2021 22:31 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $10.40 $0.00
Disclosure

SEC source: 0001213900-21-007501 · ownership.xml · derivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2031-02-03

F1 · kind: The Stock Option will vest in 4 equal installments as follows: 25,000 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

F1 · derivative.exercise_date: The Stock Option will vest in 4 equal installments as follows: 25,000 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

Read SEC document
February 03, 2021 Filed Feb 8, 2021 22:29 UTC
Hexter JoshuaCOO, Business Officer
GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $10.40 $0.00
Disclosure

SEC source: 0001213900-21-007497 · ownership.xml · derivative · entry 1

Hexter Joshua · CIK 0001573235 · COO, Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-02-03

F1 · kind: The Stock Option will vest in 4 equal installments as follows: 12,500 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

F1 · derivative.exercise_date: The Stock Option will vest in 4 equal installments as follows: 12,500 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

Read SEC document
February 03, 2021 Filed Feb 8, 2021 22:29 UTC
Gabay AvrahamCFO, Treasurer and Secretary
GrantStock Option (right to buy) · Derivative 40,000 $0.00 Strike: $10.40 $0.00
Disclosure

SEC source: 0001213900-21-007494 · ownership.xml · derivative · entry 1

Gabay Avraham · CIK 0001777328 · CFO, Treasurer and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-02-03

F1 · kind: The Stock Option will vest in 4 equal installments as follows: 10,000 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

F1 · derivative.exercise_date: The Stock Option will vest in 4 equal installments as follows: 10,000 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.

Read SEC document
January 08, 2020 Filed Jan 14, 2020 21:07 UTC
RAKIN KEVINDirector
GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001213900-20-000991 · ownership.xml · derivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-01-08

F1 · derivative.exercise_date: The Stock Option will vest in 3 installments as follows: 6,666 shall vest on December 31, 2020, and 6,667 shall vest on each of December 31, 2021 and December 31, 2022.

Read SEC document
January 08, 2020 Filed Jan 14, 2020 21:08 UTC
Sank LeonardDirector
GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001213900-20-000993 · ownership.xml · derivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-01-08

F1 · derivative.exercise_date: The Stock Option will vest in 3 installments as follows: 6,666 shall vest on December 31, 2020, and 6,667 shall vest on each of December 31, 2021 and December 31, 2022.

Read SEC document
January 08, 2020 Filed Jan 14, 2020 21:06 UTC
Mayer ArieDirector
GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001213900-20-000989 · ownership.xml · derivative · entry 1

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-01-08

F1 · derivative.exercise_date: The Stock Option will vest in 3 installments as follows: 6,666 shall vest on December 31, 2020; and 6,667 shall vest on each of December 31, 2021 and December 31, 2022.

Read SEC document
January 08, 2020 Filed Jan 14, 2020 21:06 UTC
KIDRON NADAVDirector · President and CEO · 10% owner
GrantStock Option (right to buy) · Derivative 190,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001213900-20-000988 · ownership.xml · derivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Common Stock · 190,000 shares

Expires 2030-01-08

F1 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 47,500 shall vest on each of December 31, 2020, December 31, 2021, December 31, 2022 and December 31, 2023.

Read SEC document
January 08, 2020 Filed Jan 14, 2020 21:05 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001213900-20-000985 · ownership.xml · derivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-01-08

F1 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 25,000 shall vest on each of December 31, 2020, December 31, 2021, December 31, 2022 and December 31, 2023.

Read SEC document
January 08, 2020 Filed Jan 14, 2020 21:04 UTC
Xiaoming GaoDirector
GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001213900-20-000984 · ownership.xml · derivative · entry 1

Xiaoming Gao · CIK 0001783006 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-01-08

F1 · derivative.exercise_date: The Stock Option will vest in 3 installments as follows: 6,666 shall vest on December 31, 2020, and 6,667 shall vest on each of December 31, 2021 and December 31, 2022.

Read SEC document
January 08, 2020 Filed Jan 14, 2020 21:04 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001213900-20-000983 · ownership.xml · derivative · entry 1

Friedman Aviad · CIK 0001683729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-01-08

F1 · derivative.exercise_date: The Stock Option will vest in 3 installments as follows: 6,666 shall vest on December 31, 2020, and 6,667 shall vest on each of December 31, 2021 and December 31, 2022.

Read SEC document
September 12, 2019 Filed Sep 16, 2019 22:08 UTC
RAKIN KEVINDirector
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $4.17 $0.00
Disclosure

SEC source: 0001213900-19-018200 · ownership.xml · derivative · entry 2

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2029-09-12

F1 · kind: The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option.

Read SEC document
September 12, 2019 Filed Sep 16, 2019 22:07 UTC
KIDRON NADAVDirector · President and CEO · 10% owner
GrantStock Option (right to buy) · Derivative 196,500 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0001213900-19-018199 · ownership.xml · derivative · entry 2

KIDRON NADAV · CIK 0001351779 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,500

Underlying: Common Stock · 196,500 shares

Expires 2029-09-12

F1 · kind: The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option. The option was originally granted on February 26, 2019 and provides for vesting in 4 equal installments of 49,125 on each of December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022.

F1 · derivative.exercise_date: The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option. The option was originally granted on February 26, 2019 and provides for vesting in 4 equal installments of 49,125 on each of December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022.

Read SEC document
September 12, 2019 Filed Sep 16, 2019 22:07 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantStock Option (right to buy) · Derivative 104,000 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0001213900-19-018198 · ownership.xml · derivative · entry 2

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,000

Underlying: Common Stock · 104,000 shares

Expires 2029-09-12

F1 · kind: The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option. The option was originally granted on February 26, 2019 and provides for vesting in 4 equal installments of 26,000 on each of December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022.

F1 · derivative.exercise_date: The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option. The option was originally granted on February 26, 2019 and provides for vesting in 4 equal installments of 26,000 on each of December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022.

Read SEC document
September 12, 2019 Filed Sep 16, 2019 22:06 UTC
Gabay AvrahamCFO, Treasurer and Secretary
GrantStock Option (right to buy) · Derivative 33,146 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001213900-19-018197 · ownership.xml · derivative · entry 2

Gabay Avraham · CIK 0001777328 · CFO, Treasurer and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,146

Underlying: Common Stock · 33,146 shares

Expires 2029-09-12

F1 · kind: The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option. The option was originally granted on June 17, 2019 and provides for vesting in 4 installments as follows: 5,396 shall vest on December 31, 2019; and 9,250 shall vest on each of December 31, 2020, December 31, 2021 and December 31, 2022.

F1 · derivative.exercise_date: The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option. The option was originally granted on June 17, 2019 and provides for vesting in 4 installments as follows: 5,396 shall vest on December 31, 2019; and 9,250 shall vest on each of December 31, 2020, December 31, 2021 and December 31, 2022.

Read SEC document
September 12, 2019 Filed Sep 16, 2019 22:04 UTC
Hexter JoshuaChf. Op. & Bus. Officer
GrantStock option (right to buy) · Derivative 100,000 $0.00 Strike: $3.69 $0.00
Disclosure

SEC source: 0001213900-19-018196 · ownership.xml · derivative · entry 1

Hexter Joshua · CIK 0001573235 · Chf. Op. & Bus. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2029-09-12

F1 · derivative.exercise_date: The Stock Options will vest in 16 equal installments of 6,250 on the first day of every three month period beginning November 1, 2019.

Read SEC document
September 09, 2019 Filed Sep 11, 2019 21:17 UTC
Sank LeonardDirector
PurchaseCommon Stock 10,000 $2.95 $29,500.00
Disclosure

SEC source: 0001213900-19-017770 · ownership.xml · nonDerivative · entry 2

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 374,999

Read SEC document
September 09, 2019 Filed Sep 11, 2019 21:17 UTC
Sank LeonardDirector
PurchaseCommon Stock 15,000 $2.90 $43,500.00
Disclosure

SEC source: 0001213900-19-017770 · ownership.xml · nonDerivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 364,999

Read SEC document
July 18, 2019 Filed Jul 18, 2019 17:31 UTC
Sank LeonardDirector
PurchaseCommon Stock 4,497 $3.86 $17,335.94
Disclosure

SEC source: 0001213900-19-013085 · ownership.xml · nonDerivative · entry 4

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,999

Read SEC document
July 17, 2019 Filed Jul 18, 2019 17:31 UTC
Sank LeonardDirector
PurchaseCommon Stock 10,020 $3.74 $37,496.84
Disclosure

SEC source: 0001213900-19-013085 · ownership.xml · nonDerivative · entry 3

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,502

Read SEC document
July 17, 2019 Filed Jul 18, 2019 17:31 UTC
Sank LeonardDirector
PurchaseCommon Stock 20,000 $3.58 $71,562.00
Disclosure

SEC source: 0001213900-19-013085 · ownership.xml · nonDerivative · entry 2

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,482

Read SEC document
July 16, 2019 Filed Jul 18, 2019 17:31 UTC
Sank LeonardDirector
PurchaseCommon Stock 20,000 $3.47 $69,316.00
Disclosure

SEC source: 0001213900-19-013085 · ownership.xml · nonDerivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,482

Read SEC document
July 11, 2019 Filed Jul 15, 2019 23:02 UTC
Sank LeonardDirector
PurchaseCommon Stock 1,320 $3.22 $4,250.40
Disclosure

SEC source: 0001213900-19-012780 · ownership.xml · nonDerivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,482

Read SEC document
June 17, 2019 Filed Jun 27, 2019 20:20 UTC
Gabay AvrahamCFO, Treasurer and Secretary
GrantStock Option (right to buy) · Derivative 33,146 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001213900-19-011646 · ownership.xml · derivative · entry 1

Gabay Avraham · CIK 0001777328 · CFO, Treasurer and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,146

Underlying: Common Stock · 33,146 shares

Expires 2029-06-17

F1 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 5,396 shall vest on December 31, 2019; and 9,250 shall vest on each of December 31, 2020, December 31, 2021 and December 31, 2022.

Read SEC document
June 17, 2019 Filed Sep 16, 2019 22:06 UTC
Gabay AvrahamCFO, Treasurer and Secretary
Disposition to issuerStock Option (right to buy) · Derivative 33,146 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001213900-19-018197 · ownership.xml · derivative · entry 1

Gabay Avraham · CIK 0001777328 · CFO, Treasurer and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,146 shares

Expires 2029-06-17

F1 · kind: The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option. The option was originally granted on June 17, 2019 and provides for vesting in 4 installments as follows: 5,396 shall vest on December 31, 2019; and 9,250 shall vest on each of December 31, 2020, December 31, 2021 and December 31, 2022.

F1 · derivative.exercise_date: The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option. The option was originally granted on June 17, 2019 and provides for vesting in 4 installments as follows: 5,396 shall vest on December 31, 2019; and 9,250 shall vest on each of December 31, 2020, December 31, 2021 and December 31, 2022.

Read SEC document
April 15, 2019 Filed Apr 16, 2019 21:01 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $4.13 $0.00
Disclosure

SEC source: 0001213900-19-006513 · ownership.xml · derivative · entry 1

Slager David Mark · CIK 0001477733 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2029-04-15

Read SEC document
April 10, 2019 Filed Apr 12, 2019 21:07 UTC
RAKIN KEVINDirector
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $4.17 $0.00
Disclosure

SEC source: 0001213900-19-006288 · ownership.xml · derivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2029-04-10

Read SEC document
April 10, 2019 Filed Sep 16, 2019 22:08 UTC
RAKIN KEVINDirector
Disposition to issuerStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $4.17 $0.00
Disclosure

SEC source: 0001213900-19-018200 · ownership.xml · derivative · entry 1

RAKIN KEVIN · CIK 0001184421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2029-04-10

F1 · kind: The two reported transactions involved the cancellation of an outstanding option and the grant of a replacement option.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.